|
|
|
Volumn 53, Issue 64, 1998, Pages
|
|
Therapeutic options for critically ill patients suffering from progressive lupus nephritis or Goodpasture's syndrome
a
a
a
a
a
|
|
Author keywords
Autoimmunity; Glomerulonephritis; Goodpasture's syndrome; Immunosuppressive therapy; Systemic lupus erythematosus
|
|
Indexed keywords
AZATHIOPRINE;
CORTICOSTEROID;
CYCLOPHOSPHAMIDE;
CYCLOSPORIN;
GLOMERULUS BASEMENT MEMBRANE ANTIBODY;
IMMUNOGLOBULIN;
IMMUNOSUPPRESSIVE AGENT;
METHOTREXATE;
PREDNISOLONE;
PREDNISONE;
BONE MARROW DEPRESSION;
CLINICAL FEATURE;
CLINICAL PROTOCOL;
CLINICAL TRIAL;
CONFERENCE PAPER;
CRITICAL ILLNESS;
GLOMERULONEPHRITIS;
GOODPASTURE SYNDROME;
HEMORRHAGIC CYSTITIS;
HUMAN;
IMMUNOSUPPRESSIVE TREATMENT;
INTRAVENOUS DRUG ADMINISTRATION;
LEUKOPENIA;
LUNG HEMORRHAGE;
LUPUS ERYTHEMATOSUS NEPHRITIS;
NEPHROTOXICITY;
ORAL DRUG ADMINISTRATION;
PLASMAPHERESIS;
PRACTICE GUIDELINE;
PRIORITY JOURNAL;
RISK BENEFIT ANALYSIS;
SYSTEMIC LUPUS ERYTHEMATOSUS;
DISEASE COURSE;
PATHOLOGY;
REVIEW;
ANTI-GLOMERULAR BASEMENT MEMBRANE DISEASE;
CRITICAL ILLNESS;
DISEASE PROGRESSION;
HUMANS;
LUPUS NEPHRITIS;
|
|
EID: 0031992498
PISSN: 00986577
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
|
Times cited : (10)
|
|
References (92)
|
